Kosuke Yusa

10PUBLICATIONS

100CO-AUTHORS

Predictive and prognostic markersBiological network analysisPowder and particle technologyMolecular targetsEpigenetics (incl. genome methylation and epigenomics)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (10)

Sort by Publication Date:

|Jun 10, 2026

CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition.

|Mar 12, 2026

A novel CDK12 inhibitor induces homologous recombination deficiency to enhance PARP inhibitor efficacy in uterine serous carcinoma.

Shunsuke Kawahara, Mana Taki, Junzo Hamanishi

|Dec 28, 2023

RENGE infers gene regulatory networks using time-series single-cell RNA-seq data with CRISPR perturbations.

Masato Ishikawa, Seiichi Sugino, Yoshie Masuda

|Jan 30, 2023

B1 SINE-binding ZFP266 impedes mouse iPSC generation through suppression of chromatin opening mediated by reprogramming factors.

Daniel F Kaemena, Masahito Yoshihara, Meryam Beniazza

|Oct 14, 2022

AKT-mTORC1 reactivation is the dominant resistance driver for PI3Kβ/AKT inhibitors in PTEN-null breast cancer and can be overcome by combining with Mcl-1 inhibitors.

Shanade Dunn, Cath Eberlein, Jason Yu

|Mar 25, 2022

Genome-wide screening identifies Polycomb repressive complex 1.3 as an essential regulator of human naïve pluripotent cell reprogramming.

Amanda J Collier, Adam Bendall, Charlene Fabian

Pageof 2

Frequent Collaborators

Yusuke Tarumoto

Hiroko Yamakawa

George Vassiliou

Shafiqul Islam

Zoe Hewitt

John Alexander

Andrew Wood

Richard Weightman

Sian Gregory

Paul J Gokhale

Frequent Collaborators

Yusuke Tarumoto

Hiroko Yamakawa

George Vassiliou

Shafiqul Islam